BlackRock, Inc. has cut its voting rights in ChemoMetec A/S to 14.95%, just below the legal limit.

BLK · BlackRock, Inc.

The AI's read

This changes BlackRock's reported voting position in another company, not its own products, sales, or operations. The notice gives no change to BlackRock's business or profit. Rights tied to financial instruments also bring its combined position above 15%, but no business consequence is reported.